According to Zoetis's latest financial reports and stock price the company's current Operating Margin is 34.39%. At the end of 2022 the company had an Operating Margin of 35.61%.
Year | Operating Margin | Change |
---|---|---|
2022 | 35.61% | 2.09% |
2021 | 34.88% | 4.54% |
2020 | 33.36% | 3.19% |
2019 | 32.33% | -0.67% |
2018 | 32.55% | 1.61% |
2017 | 32.03% | 12.32% |
2016 | 28.52% | 103.13% |
2015 | 14.04% | -28.3% |
2014 | 19.58% | 11.22% |
2013 | 17.61% | 3.02% |
2012 | 17.09% | 68.23% |
2011 | 10.16% | 69.24% |
2010 | 6.00% | -235.79% |
2009 | -4.42% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Pfizer PFE | 34.61% | 0.64% | ๐บ๐ธ USA |
Eli Lilly LLY | 24.66% | -28.29% | ๐บ๐ธ USA |
Sanofi SNY | 18.21% | -47.05% | ๐ซ๐ท France |
Merck MRK | 27.73% | -19.37% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | 6.13% | -82.18% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | -500.90% | -1,556.52% | ๐บ๐ธ USA |
Heska Corporation
HSKA | -1.35% | -103.93% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.